These findings suggest that CtBP1 may play a key role in the chemosensitivity of ESCC cells to paclitaxel, and that targeting CtBP1 may be a promising strategy for inhibiting colony formation and the proliferation of ESCC cells. The gene discussed is CTBP1; the disease is esophageal squamous cell carcinoma.